Skip to main content
Top
Published in: Journal of Cancer Survivorship 2/2016

01-04-2016

Surgical lung cancer patients’ views about smoking and support to quit after diagnosis: a qualitative study

Authors: Amanda Farley, Paul Aveyard, Amy Kerr, Babu Naidu, George Dowswell

Published in: Journal of Cancer Survivorship | Issue 2/2016

Login to get access

Abstract

Purpose

Evidence suggests that quitting smoking improves symptoms as well as disease-related mortality for cancer patients. However, smoking cessation support is typically not well integrated into routine cancer care even in the case of lung cancer.. We explored surgical lung cancer patients’ views about smoking and about their preferences for support to help them to quit.

Methods

We conducted semi-structured, qualitative interviews with 22 surgical lung cancer patients with a smoking history, after treatment with surgery. Data were analysed using the framework approach.

Results

Although diagnosis promoted a successful quit attempt in some, others continued smoking or relapsed after a quit attempt. Most participants wished they were a non-smoker but, in conflict with this, also felt that smoking was enjoyable, helped with psychological coping or had some health benefits. Some also demonstrated a fatalist attitude towards the potential detrimental health effects. However, all participants felt that it was important for health professionals to address smoking and some wanted cessation support although it was often not provided. Participants wanted support to start as early as possible and to continue for the first weeks after discharge.

Conclusions

Surgical lung cancer patients often stop smoking during hospitalisation, and many want to remain quit but relapse shortly after discharge. Although it is often not provided, many patients want to be offered support to help them quit.

Implications for Cancer Survivors

Surveys suggest that clinicians believe that addressing smoking will be difficult and/or unwanted. However, these findings suggest that surgical lung cancer patients would tolerate, and most would prefer, integration of smoking cessation support into routine cancer care.
Literature
1.
2.
go back to reference Khunder SA. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer. 2001;31:139–48.CrossRef Khunder SA. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer. 2001;31:139–48.CrossRef
5.
go back to reference Cooley ME, Sarna L, Kotlerman J, et al. Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent. Lung Cancer. 2009;66:218–25.CrossRefPubMedPubMedCentral Cooley ME, Sarna L, Kotlerman J, et al. Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent. Lung Cancer. 2009;66:218–25.CrossRefPubMedPubMedCentral
6.
go back to reference Dresler CM, Bailey M, Roper CR, et al. Smoking cessation and lung cancer resection. CHEST J. 1996;110:1199–202.CrossRef Dresler CM, Bailey M, Roper CR, et al. Smoking cessation and lung cancer resection. CHEST J. 1996;110:1199–202.CrossRef
7.
9.
go back to reference Garces YI, Yang P, Parkinson J, et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. CHEST J. 2004;126:1733–41.CrossRef Garces YI, Yang P, Parkinson J, et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. CHEST J. 2004;126:1733–41.CrossRef
10.
go back to reference Daniel M, Keefe FJ, Lyna P, et al. Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levels. J Pain. 2009;10:323–8.CrossRefPubMedPubMedCentral Daniel M, Keefe FJ, Lyna P, et al. Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levels. J Pain. 2009;10:323–8.CrossRefPubMedPubMedCentral
11.
go back to reference Moller AM, Villebro N, Pedersen T, et al. Effect of preoperative smoking intervention on postoperative complications; a randomised clinical trial. Lancet. 2002;359:114–7.CrossRefPubMed Moller AM, Villebro N, Pedersen T, et al. Effect of preoperative smoking intervention on postoperative complications; a randomised clinical trial. Lancet. 2002;359:114–7.CrossRefPubMed
12.
go back to reference Erhunmwunsee L, Onaitis M. Smoking cessation and the success of lung cancer surgery. Curr Oncol Rep. 2009;11:269–74.CrossRefPubMed Erhunmwunsee L, Onaitis M. Smoking cessation and the success of lung cancer surgery. Curr Oncol Rep. 2009;11:269–74.CrossRefPubMed
13.
go back to reference Parsons A, Daley A, Begh R, et al. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010;340:B5569.CrossRefPubMedPubMedCentral Parsons A, Daley A, Begh R, et al. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010;340:B5569.CrossRefPubMedPubMedCentral
14.
go back to reference Warren G, Marshall J, Cummings KM, et al. Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients. J Thorac Oncol. 2013;8:543–8.CrossRefPubMedPubMedCentral Warren G, Marshall J, Cummings KM, et al. Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients. J Thorac Oncol. 2013;8:543–8.CrossRefPubMedPubMedCentral
15.
go back to reference Warren GW, Marshall JR, Cummings KM, et al. Addressing tobacco use in patients with cancer: a survey of American society of clinical oncology member. J Oncol Pract. 2013;9:258–62.CrossRefPubMedPubMedCentral Warren GW, Marshall JR, Cummings KM, et al. Addressing tobacco use in patients with cancer: a survey of American society of clinical oncology member. J Oncol Pract. 2013;9:258–62.CrossRefPubMedPubMedCentral
16.
go back to reference Dresler CM, Gritz ER. Smoking, smoking cessation and the oncologist. Lung Cancer. 2001;34:315–23.CrossRefPubMed Dresler CM, Gritz ER. Smoking, smoking cessation and the oncologist. Lung Cancer. 2001;34:315–23.CrossRefPubMed
17.
go back to reference Richie J, Lewis J. Qualitative research practice. 1st ed. Sage, 2007 Richie J, Lewis J. Qualitative research practice. 1st ed. Sage, 2007
19.
go back to reference Fidler JA, West R. Self-perceived smoking motives and their correlates in a general population sample. Nicotine Tob Res. 2009;11:1182–8.CrossRefPubMed Fidler JA, West R. Self-perceived smoking motives and their correlates in a general population sample. Nicotine Tob Res. 2009;11:1182–8.CrossRefPubMed
20.
go back to reference LoConte NK, Else-Quest NM, Eickhoff J, Hyde J, Schiller JH. Assessment of guilt and shame in patients with non-small cell lung cancer compared with patients with breast and prostate cancer. Clin Lung Cancer. 2008;9(3):171–8.CrossRefPubMed LoConte NK, Else-Quest NM, Eickhoff J, Hyde J, Schiller JH. Assessment of guilt and shame in patients with non-small cell lung cancer compared with patients with breast and prostate cancer. Clin Lung Cancer. 2008;9(3):171–8.CrossRefPubMed
21.
go back to reference Halding AG, Heggdal K, Wahl A. Experiences of self-blame and stigmatisation for self-inflication among individuals livings with COPD. Scand J Caring Sci. 2011;25:100–7.CrossRefPubMed Halding AG, Heggdal K, Wahl A. Experiences of self-blame and stigmatisation for self-inflication among individuals livings with COPD. Scand J Caring Sci. 2011;25:100–7.CrossRefPubMed
22.
go back to reference Steinberg MB, Schmelzer AC, Lin PN, et al. Smoking as a chronic disease. Curr Cardiol Risk. 2010;4:413–20.CrossRef Steinberg MB, Schmelzer AC, Lin PN, et al. Smoking as a chronic disease. Curr Cardiol Risk. 2010;4:413–20.CrossRef
23.
go back to reference Wong J, Lam D, Abrishami A, et al. Short-term preoperative smoking cessation and postoperative complication: a systematic review and meta-analysis. Can J Anesth. 2012;59:268–79.CrossRefPubMed Wong J, Lam D, Abrishami A, et al. Short-term preoperative smoking cessation and postoperative complication: a systematic review and meta-analysis. Can J Anesth. 2012;59:268–79.CrossRefPubMed
24.
go back to reference Mason DP, Subramanian S, Nowicki ER, et al. Impact of smoking cessation before resection of lung cancer: a society of thoracic surgeons general thoracic surgery database study. Ann Thorac Surg. 2009;88:362–71.CrossRefPubMed Mason DP, Subramanian S, Nowicki ER, et al. Impact of smoking cessation before resection of lung cancer: a society of thoracic surgeons general thoracic surgery database study. Ann Thorac Surg. 2009;88:362–71.CrossRefPubMed
26.
go back to reference Thomsen T, Tonnesen H, Moller AM. Effect of preoperative smoking cessation interventions on postoperative complications and smoking cessation. Br J Surg. 2009;96:451–61.CrossRefPubMed Thomsen T, Tonnesen H, Moller AM. Effect of preoperative smoking cessation interventions on postoperative complications and smoking cessation. Br J Surg. 2009;96:451–61.CrossRefPubMed
27.
go back to reference National Institute of Health and Clinical Excellence. Smoking cessation in secondary care: acute, maternity and mental health services. 2013;NICE guidelines [PH48] National Institute of Health and Clinical Excellence. Smoking cessation in secondary care: acute, maternity and mental health services. 2013;NICE guidelines [PH48]
Metadata
Title
Surgical lung cancer patients’ views about smoking and support to quit after diagnosis: a qualitative study
Authors
Amanda Farley
Paul Aveyard
Amy Kerr
Babu Naidu
George Dowswell
Publication date
01-04-2016
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 2/2016
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-015-0477-4

Other articles of this Issue 2/2016

Journal of Cancer Survivorship 2/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine